Published Trial Results Indicate High Sensitivity and Reproducibility of Early Colon Cancer Detection by ColoMarker Blood Test

The publication entitled CA 11-19: A Tumor Marker for the Diagnosis of Colorectal Cancer, is published in the September issue of the Journal of Gastrointestinal Endoscopy. Clinical performance of ColoMarker was determined utilizing a cohort of 522 consecutively collected serum samples that were obtained under a multi-center IRB protocol. Blood samples were blinded and clinical status was confirmed with colonoscopy prior to testing. Additionally, reproducibility of ColoMarker was evaluated using blinded, duplicate samples run in two US locations and then analysed.